Related Experiment Video
Updated: Jun 11, 2025
09:01
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
300
Sonocatalysis Regulates Tumor Autophagy for Enhanced Immunotherapy
Yihan Fu1, Yuchu He1, Xindi Wei2
1State Key Laboratory of Metastable Materials Science and Technology, Nano-Biotechnology Key Lab of Hebei Province, Applying Chemistry Key Lab of Hebei Province, Yanshan University, Qinhuangdao 066004, P. R. China.
ACS Nano
|October 8, 2024
Summary
This study introduces a novel nanocatalyst that uses ultrasound to inhibit tumor autophagy, a key resistance mechanism. This approach enhances cancer immunotherapy by promoting tumor cell death and boosting immune responses.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cancer Research
Background:
- Immunotherapy is a promising cancer treatment, but its effectiveness is limited by tumor autophagy.
- Tumor autophagy allows cancer cells to resist immune attacks and treatments.
Purpose of the Study:
- To develop a spatiotemporally controlled method to modulate tumor autophagy using sonocatalysis.
- To enhance the efficacy of cancer immunotherapy by overcoming tumor resistance.
Main Methods:
- Synthesis of a tumor-targeting nanocatalyst (Barium Titanate/Black Phosphorus-Hyaluronic Acid - BTO/BP-HA).
- Utilizing ultrasonic stimulation to activate the nanocatalyst for sonocatalysis.
- Investigating the mechanism of autophagy inhibition via lysosomal pH modulation.
Main Results:
- The BTO/BP-HA nanocatalyst, under ultrasound, generates H2, promoting tumor cell apoptosis and immunogenic cell death.
- Nanocatalyst-induced degradation of Black Phosphorus increases lysosomal pH, inhibiting autophagy.
- Inhibition of autophagy enhances the cytotoxic effects of the nanocatalyst and boosts anti-tumor immune responses.
Conclusions:
- Sonocatalysis combined with nanocatalyst design offers a novel strategy to inhibit tumor autophagy.
- This approach significantly enhances the effectiveness of cancer immunotherapy by overcoming a major resistance mechanism.
- The developed BTO/BP-HA nanocatalyst shows potential for improving cancer treatment outcomes.
Related Concept Videos
01:27Tumor Immunotherapy
489
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
489
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K